 | • レポートコード：MRC2-11QY11878 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は鼻血治療薬のグローバル市場について調査・分析したレポートです。種類別（血管収縮剤、麻酔薬、抗生物質軟膏、焼灼剤、その他）市場規模、用途別（病院、クリニック、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別鼻血治療薬の競争状況、市場シェア ・世界の鼻血治療薬市場：種類別市場規模 2015年-2020年（血管収縮剤、麻酔薬、抗生物質軟膏、焼灼剤、その他） ・世界の鼻血治療薬市場：種類別市場規模予測 2021年-2026年（血管収縮剤、麻酔薬、抗生物質軟膏、焼灼剤、その他） ・世界の鼻血治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、小売薬局、その他） ・世界の鼻血治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、小売薬局、その他） ・北米の鼻血治療薬市場分析：米国、カナダ ・ヨーロッパの鼻血治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの鼻血治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の鼻血治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの鼻血治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、GlaxoSmithKline、Smith & Nephew、Bristol-Myers Squibb、Medline Industries、Ciron Drugs & Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A epistaxis, also known as nosebleed, is the common occurrence of bleeding from the nose. It is usually noticed when blood drains out through the nostrils.
Epistaxis continues to remain a common health problem observed among the adults and children. Impact of extreme weather conditions can lead to crusting of the mucous secretion processes, which can result into cracks in the nose lining.
Market Analysis and Insights: Global Epistaxis Drugs Market
The global Epistaxis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Epistaxis Drugs Scope and Market Size
Epistaxis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epistaxis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
GlaxoSmithKline
Smith & Nephew
Bristol-Myers Squibb
Medline Industries
Ciron Drugs & Pharmaceuticals
…
Market segment by Type, the product can be split into
Vasoconstrictors
Anesthetics
Antibiotic Ointments
Cauterizing Agents
Others
Market segment by Application, split into
Hospitals
Clinics
Retail Pharmacies
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epistaxis Drugs Revenue
1.4 Market by Type
1.4.1 Global Epistaxis Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Vasoconstrictors
1.4.3 Anesthetics
1.4.4 Antibiotic Ointments
1.4.5 Cauterizing Agents
1.4.6 Others
1.5 Market by Application
1.5.1 Global Epistaxis Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Retail Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Epistaxis Drugs Market Perspective (2015-2026)
2.2 Global Epistaxis Drugs Growth Trends by Regions
2.2.1 Epistaxis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epistaxis Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Epistaxis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epistaxis Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Epistaxis Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Epistaxis Drugs Players by Market Size
3.1.1 Global Top Epistaxis Drugs Players by Revenue (2015-2020)
3.1.2 Global Epistaxis Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Epistaxis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epistaxis Drugs Market Concentration Ratio
3.2.1 Global Epistaxis Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epistaxis Drugs Revenue in 2019
3.3 Epistaxis Drugs Key Players Head office and Area Served
3.4 Key Players Epistaxis Drugs Product Solution and Service
3.5 Date of Enter into Epistaxis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Epistaxis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Epistaxis Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Epistaxis Drugs Market Size by Application (2015-2020)
5.2 Global Epistaxis Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Epistaxis Drugs Market Size (2015-2020)
6.2 Epistaxis Drugs Key Players in North America (2019-2020)
6.3 North America Epistaxis Drugs Market Size by Type (2015-2020)
6.4 North America Epistaxis Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Epistaxis Drugs Market Size (2015-2020)
7.2 Epistaxis Drugs Key Players in Europe (2019-2020)
7.3 Europe Epistaxis Drugs Market Size by Type (2015-2020)
7.4 Europe Epistaxis Drugs Market Size by Application (2015-2020)
8 China
8.1 China Epistaxis Drugs Market Size (2015-2020)
8.2 Epistaxis Drugs Key Players in China (2019-2020)
8.3 China Epistaxis Drugs Market Size by Type (2015-2020)
8.4 China Epistaxis Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Epistaxis Drugs Market Size (2015-2020)
9.2 Epistaxis Drugs Key Players in Japan (2019-2020)
9.3 Japan Epistaxis Drugs Market Size by Type (2015-2020)
9.4 Japan Epistaxis Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Epistaxis Drugs Market Size (2015-2020)
10.2 Epistaxis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epistaxis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Epistaxis Drugs Market Size by Application (2015-2020)
11 India
11.1 India Epistaxis Drugs Market Size (2015-2020)
11.2 Epistaxis Drugs Key Players in India (2019-2020)
11.3 India Epistaxis Drugs Market Size by Type (2015-2020)
11.4 India Epistaxis Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Epistaxis Drugs Market Size (2015-2020)
12.2 Epistaxis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Epistaxis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Epistaxis Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Epistaxis Drugs Introduction
13.1.4 Pfizer Revenue in Epistaxis Drugs Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Epistaxis Drugs Introduction
13.2.4 GlaxoSmithKline Revenue in Epistaxis Drugs Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Smith & Nephew
13.3.1 Smith & Nephew Company Details
13.3.2 Smith & Nephew Business Overview
13.3.3 Smith & Nephew Epistaxis Drugs Introduction
13.3.4 Smith & Nephew Revenue in Epistaxis Drugs Business (2015-2020)
13.3.5 Smith & Nephew Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview
13.4.3 Bristol-Myers Squibb Epistaxis Drugs Introduction
13.4.4 Bristol-Myers Squibb Revenue in Epistaxis Drugs Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Medline Industries
13.5.1 Medline Industries Company Details
13.5.2 Medline Industries Business Overview
13.5.3 Medline Industries Epistaxis Drugs Introduction
13.5.4 Medline Industries Revenue in Epistaxis Drugs Business (2015-2020)
13.5.5 Medline Industries Recent Development
13.6 Ciron Drugs & Pharmaceuticals
13.6.1 Ciron Drugs & Pharmaceuticals Company Details
13.6.2 Ciron Drugs & Pharmaceuticals Business Overview
13.6.3 Ciron Drugs & Pharmaceuticals Epistaxis Drugs Introduction
13.6.4 Ciron Drugs & Pharmaceuticals Revenue in Epistaxis Drugs Business (2015-2020)
13.6.5 Ciron Drugs & Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Epistaxis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Epistaxis Drugs Revenue
Table 3. Ranking of Global Top Epistaxis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epistaxis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Vasoconstrictors
Table 6. Key Players of Anesthetics
Table 7. Key Players of Antibiotic Ointments
Table 8. Key Players of Cauterizing Agents
Table 9. Key Players of Others
Table 10. Global Epistaxis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Epistaxis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Epistaxis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Epistaxis Drugs Market Share by Regions (2015-2020)
Table 14. Global Epistaxis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Epistaxis Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Epistaxis Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Epistaxis Drugs Players
Table 21. Global Epistaxis Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Epistaxis Drugs Market Share by Players (2015-2020)
Table 23. Global Top Epistaxis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epistaxis Drugs as of 2019)
Table 24. Global Epistaxis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Epistaxis Drugs Product Solution and Service
Table 27. Date of Enter into Epistaxis Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Epistaxis Drugs Market Size Share by Type (2015-2020)
Table 31. Global Epistaxis Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Epistaxis Drugs Market Size Share by Application (2015-2020)
Table 33. Global Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Epistaxis Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Epistaxis Drugs Market Share (2019-2020)
Table 37. North America Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Epistaxis Drugs Market Share by Type (2015-2020)
Table 39. North America Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Epistaxis Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Epistaxis Drugs Market Share (2019-2020)
Table 43. Europe Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Epistaxis Drugs Market Share by Type (2015-2020)
Table 45. Europe Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Epistaxis Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Epistaxis Drugs Market Share (2019-2020)
Table 49. China Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Epistaxis Drugs Market Share by Type (2015-2020)
Table 51. China Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Epistaxis Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Epistaxis Drugs Market Share (2019-2020)
Table 55. Japan Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Epistaxis Drugs Market Share by Type (2015-2020)
Table 57. Japan Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Epistaxis Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Epistaxis Drugs Market Share (2019-2020)
Table 61. Southeast Asia Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Epistaxis Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Epistaxis Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Epistaxis Drugs Market Share (2019-2020)
Table 67. India Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Epistaxis Drugs Market Share by Type (2015-2020)
Table 69. India Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Epistaxis Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Epistaxis Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Epistaxis Drugs Market Share (2019-2020)
Table 73. Central & South America Epistaxis Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Epistaxis Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Epistaxis Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Epistaxis Drugs Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Epistaxis Drugs Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Epistaxis Drugs Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Smith & Nephew Company Details
Table 88. Smith & Nephew Business Overview
Table 89. Smith & Nephew Product
Table 90. Smith & Nephew Revenue in Epistaxis Drugs Business (2015-2020) (Million US$)
Table 91. Smith & Nephew Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Product
Table 95. Bristol-Myers Squibb Revenue in Epistaxis Drugs Business (2015-2020) (Million US$)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Medline Industries Company Details
Table 98. Medline Industries Business Overview
Table 99. Medline Industries Product
Table 100. Medline Industries Revenue in Epistaxis Drugs Business (2015-2020) (Million US$)
Table 101. Medline Industries Recent Development
Table 102. Ciron Drugs & Pharmaceuticals Company Details
Table 103. Ciron Drugs & Pharmaceuticals Business Overview
Table 104. Ciron Drugs & Pharmaceuticals Product
Table 105. Ciron Drugs & Pharmaceuticals Revenue in Epistaxis Drugs Business (2015-2020) (Million US$)
Table 106. Ciron Drugs & Pharmaceuticals Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epistaxis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Vasoconstrictors Features
Figure 3. Anesthetics Features
Figure 4. Antibiotic Ointments Features
Figure 5. Cauterizing Agents Features
Figure 6. Others Features
Figure 7. Global Epistaxis Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Others Case Studies
Figure 12. Epistaxis Drugs Report Years Considered
Figure 13. Global Epistaxis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Epistaxis Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Epistaxis Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Epistaxis Drugs Market Share by Players in 2019
Figure 18. Global Top Epistaxis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epistaxis Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Epistaxis Drugs Revenue in 2019
Figure 20. North America Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Epistaxis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- 抗てんかん薬の世界市場（～2026年） Market Analysis and Insights: Global Antiepileptic Drugs Market The global Antiepileptic Drugs market size is projected to reach US$ 4076.9 million by 2026, from US$ 3984.1 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Antiepileptic Drugs Scope and Market Size Antiepileptic Drugs mark…
- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…